CLS vs TECH · P/E 44, rev $9.65B vs P/E 65, rev $1.22B
Celestica Inc. (CLS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Celestica Inc. (CLS) is a electronic components company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CLS revenue for 2024-12-31 was $9.65B. Net income was $428.0M. Revenue was up 21.2% from 2023-12-31 to 2024-12-31. CLS currently screens at market cap $17.99B and trailing P/E 43.6.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CLS currently screens at market cap $17.99B and trailing P/E 43.6. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CLS and TECH stock pages for the full models.
Not investment advice.